Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TERN - Madrigal: Rezdiffra Launch Gets Underway The Only Competition Is Off-Label

TERN - Madrigal: Rezdiffra Launch Gets Underway The Only Competition Is Off-Label

Terns Pharmaceuticals Inc.

2024-04-30 16:30:23 ET

Summary

  • MDGL has launched Rezdiffra, the first drug approved for nonalcoholic steatohepatitis (NASH).
  • Rezdiffra faces competition from potential off-label use of GLP-1RA drugs like semaglutide and tirzepatide, but there is potential for combination therapy too.
  • Shortages of semaglutide and tirzepatide could help Rezdiffra's initial launch.

...

For further details see:

Madrigal: Rezdiffra Launch Gets Underway, The Only Competition Is Off-Label
Stock Information
Company Name: Terns Pharmaceuticals Inc.
Stock Symbol: TERN
Market: NASDAQ
Website: ternspharma.com
Menu
TERN TERN Quote TERN Short TERN News TERN Articles TERN Message Board
Get TERN Alerts

News, Short Squeeze, Breakout and More Instantly...